BIPERIDEN HYDROCHLORIDE - Generic Drug Details
What are the generic sources for biperiden hydrochloride and what is the scope of patent protection?
Biperiden hydrochloride
is the generic ingredient in one branded drug marketed by Abbvie and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for BIPERIDEN HYDROCHLORIDE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| Clinical Trials: | 10 |
| DailyMed Link: | BIPERIDEN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BIPERIDEN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| PROADI-SUS | Phase 3 |
| Ministry of Health, Brazil | Phase 3 |
| Hospital Sirio-Libanes | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for BIPERIDEN HYDROCHLORIDE
US Patents and Regulatory Information for BIPERIDEN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | AKINETON | biperiden hydrochloride | TABLET;ORAL | 012003-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
